Literature DB >> 34268083

Preoperative prediction of axillary lymph node metastasis in patients with breast cancer based on radiomics of gray-scale ultrasonography.

Wei-Jun Zhou1,2, Yi-Dan Zhang3, Wen-Tao Kong3, Chao-Xue Zhang2, Bing Zhang1,4.   

Abstract

BACKGROUND: To investigate the performance of a radiomics model based on gray-scale ultrasonography (US) for the preoperative non-invasive prediction of ipsilateral axillary lymph node (ALN) metastasis in patients with breast cancer (BC).
METHODS: A total of 192 pathologically confirmed BC patients were included in this study. The training set was comprised of 132 patients from hospital 1 and the test set was comprised of 60 patients from hospital 2. All patients underwent US before percutaneous core biopsy and the results of ALN status reported by a radiologist with 12 years of experience were recorded. Radiomic features were extracted from the gray-scale US images. Max-relevance and min-redundancy (MRMR) and least absolute shrinkage and selection operator (LASSO) were used for data dimension reduction and feature selection. A radiomics model was constructed using LASSO and was validated using the leave group out cross-validation (LGOCV) method. The performance of the model was validated with receiver operating characteristic (ROC), calibration curve, and decision curve analysis.
RESULTS: A total of 860 features were extracted from the gray-scale US images of each breast lesion, and 9 radiomic features were selected for model construction. The area under the curve (AUC), sensitivity, and specificity of the model for predicting ALN metastasis were 0.85, 78.9%, and 77.3% in the training set and 0.65, 68.0%, and 79.4% in the test set, respectively. The prediction performance of the model was significantly higher than that of the radiologist (AUC: 0.85 vs. 0.59, P<0.01) in the training set and was slightly higher than that of the radiologist (AUC: 0.65 vs. 0.63, P>0.05) in the test set.
CONCLUSIONS: The non-invasive radiomics model has the ability to predict ALN metastasis for patients with breast cancer and may outperform US-reported ALN status performed by the radiologist. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Radiomics; axillary lymph node (ALN); breast cancer (BC); gray-scale; ultrasound

Year:  2021        PMID: 34268083      PMCID: PMC8258890          DOI: 10.21037/gs-21-315

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  31 in total

1.  Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy.

Authors:  Hanchuan Peng; Fuhui Long; Chris Ding
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2005-08       Impact factor: 6.226

2.  Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer.

Authors:  Rikiya Nakamura; Naohito Yamamoto; Toshiko Miyaki; Makiko Itami; Nobumitsu Shina; Masayuki Ohtsuka
Journal:  Breast Cancer       Date:  2017-07-22       Impact factor: 4.239

3.  Preoperative axillary lymph node staging in early breast cancer: Diagnostic efficacy and histopathology correlation.

Authors:  Filipa Ferreira da Silva; Maria de Lurdes Orvalho; Augusto Gaspar; Paulina Viana Lopes; João Leal de Faria; Ana Catarino; Mónica Nave; José Luís Passos-Coelho
Journal:  Breast J       Date:  2019-07-23       Impact factor: 2.431

Review 4.  Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.

Authors:  Marie Catherine Lee; Jennifer E Joh; Alec Chau
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

5.  Axillary Lymph Node Sonographic Features and Breast Tumor Characteristics as Predictors of Malignancy: A Nomogram to Predict Risk.

Authors:  Patricia Akissue de Camargo Teixeira; Luciano F Chala; Carlos Shimizu; José R Filassi; Jonathan Y Maesaka; Nestor de Barros
Journal:  Ultrasound Med Biol       Date:  2017-06-17       Impact factor: 2.998

Review 6.  Rapid review: radiomics and breast cancer.

Authors:  Francesca Valdora; Nehmat Houssami; Federica Rossi; Massimo Calabrese; Alberto Stefano Tagliafico
Journal:  Breast Cancer Res Treat       Date:  2018-02-02       Impact factor: 4.872

7.  Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

Authors:  Zhenyu Liu; Xiao-Yan Zhang; Yan-Jie Shi; Lin Wang; Hai-Tao Zhu; Zhenchao Tang; Shuo Wang; Xiao-Ting Li; Jie Tian; Ying-Shi Sun
Journal:  Clin Cancer Res       Date:  2017-09-22       Impact factor: 12.531

8.  Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Authors:  Lei Yang; Di Dong; Mengjie Fang; Yongbei Zhu; Yali Zang; Zhenyu Liu; Hongmei Zhang; Jianming Ying; Xinming Zhao; Jie Tian
Journal:  Eur Radiol       Date:  2018-01-15       Impact factor: 5.315

Review 9.  Imaging-Based Approach to Axillary Lymph Node Staging and Sentinel Lymph Node Biopsy in Patients With Breast Cancer.

Authors:  Susie X Sun; Tanya W Moseley; Henry M Kuerer; Wei T Yang
Journal:  AJR Am J Roentgenol       Date:  2019-11-12       Impact factor: 3.959

10.  Predictive performance of ultrasonography-based radiomics for axillary lymph node metastasis in the preoperative evaluation of breast cancer.

Authors:  Si Eun Lee; Yongsik Sim; Sungwon Kim; Eun-Kyung Kim
Journal:  Ultrasonography       Date:  2020-04-01
View more
  2 in total

1.  A ultrasound-based radiomic approach to predict the nodal status in clinically negative breast cancer patients.

Authors:  Samantha Bove; Maria Colomba Comes; Annarita Fanizzi; Raffaella Massafra; Vito Lorusso; Cristian Cristofaro; Vittorio Didonna; Gianluca Gatta; Francesco Giotta; Daniele La Forgia; Agnese Latorre; Maria Irene Pastena; Nicole Petruzzellis; Domenico Pomarico; Lucia Rinaldi; Pasquale Tamborra; Alfredo Zito
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.996

Review 2.  Ultrasound radiomics in personalized breast management: Current status and future prospects.

Authors:  Jionghui Gu; Tian'an Jiang
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.